Breast cancer is the most malignant and major cause of cancer-related deaths among women worldwide [1], which is classified into hormone-receptor-positive, human epidermal growth factor receptor-2 overexpressing (HER2+) and triple-negative breast cancer (TNBC) based on histological features. This evidence concerns the gene ERBB2 and breast cancer.